Severe Asthma and Related Eosinophilic Diseases: The Role of IL-5 in Diagnosis and Treatment

Published: March 31, 2020, 4 a.m.

Guest: Ron Balkissoon, MD
Guest: Eileen Wang, MD, MPH

This 45-minute enduring activity (three 15 minute chapters) covers the role of eosinophils and type 2 inflammation in severe asthma and eosinophil-related diseases. Understanding how to identify the mechanisms of action for biologic therapies can aid providers in selecting appropriate treatments for patients with these diseases. Using the clinical presentation and diagnostic test results, providers will learn about current and emerging treatments and recent clinical studies on approved agents that can help with treatment selection and indications of when it is appropriate to refer to a specialist.